EFFECT ·Filed Apr 3, 2026

SNGX

SOLIGENIX, INC.
BEARISH
Impact 6/10
Horizondays Processed6mo ago SEC9999999995-26-001064
Actionable Insight ▼ Bearish

Monitor for imminent pricing supplements or prospectus filings that will reveal offering size, price, and use of proceeds. Given the small market cap, even a modest equity raise could lead to sharp downside pressure on the stock. Consider hedging or reducing exposure ahead of any announced offering.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
SNGX ▼ -65.18% at T+60d
SHORT call ✓ call won +65.18% · α vs SPY +78.64% · entry $1.14 → $0.3970
Entry anchored
Apr 2, 03:59 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α +0.06%
$1.14
settled 6mo ago
T+5d
+0.88%
call -0.88% · α +3.26%
$1.15
settled 6mo ago
T+20d
-69.30%
call +69.30% · α +78.28%
$0.3500
settled 5mo ago
T+60d
-65.18%
call +65.18% · α +78.64%
$0.3970
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Soligenix, Inc. (SNGX) has had four separate shelf registration statements (Forms S-3) become effective, allowing the company to raise capital through future offerings of securities. The filings do not disclose specific offering sizes or terms, but signal potential dilution risk given the company's small $12M market cap.

Key Facts

  • Four EFFECT filings were submitted on April 3, 2026, with effectiveness dated April 2, 2026.
  • Each relates to a previously filed Form S-3 shelf registration: 333-290413, 333-280993, 333-276511, and 333-271049.
  • No specific offering size, price, or security type is disclosed in the EFFECT notices.
  • Company has a market capitalization of $12M, making any future equity issuance highly dilutive.
  • Multiple concurrent effective shelf registrations suggest an aggressive capital-raising posture.

Financial Impact

Potential for significant dilution depending on future offering size and pricing.

dilutionequitymarket_cap

Risk Factors

  • Significant share dilution from upcoming equity offerings
  • Downward pressure on stock price due to supply overhang
  • Lack of transparency on use of proceeds or offering terms

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 12 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (SNGX) — Batch item 19999999995-26-001064
Document: 9999999995-26-001064-index.html9999999995-26-001059
Document: 9999999995-26-001064.txt9999999995-26-001056
EFFECT Filing (SNGX) — Batch item 49999999995-26-001059
Document: 9999999995-26-001059-index.html9999999995-26-001064
Document: 9999999995-26-001059.txt9999999995-26-001064
EFFECT Filing (SNGX) — Batch item 79999999995-26-001056
Document: 9999999995-26-001056-index.html9999999995-26-001064
Document: 9999999995-26-001056.txt9999999995-26-001064
EFFECT Filing (SNGX) — Batch item 109999999995-26-001058
Document: 9999999995-26-001058-index.html9999999995-26-001064
Document: 9999999995-26-001058.txt9999999995-26-001064
5 reports for SNGX
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +56.04%May 28, 2026
Filters
Rows
Reports for SNGX — sortable, filterable
TypeNow
Jun 26, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.4000 $0.3850▲ +3.75%▲ +8.14%$0.3659 (+8.52%)
Jun 26, 2026
13w ago
424B5
BEARISH ★ 7/10
$0.4000 $0.3850▲ +3.75%▲ +8.14%$0.3659 (+8.52%)
May 28, 2026
18w ago
8-K
BEARISH ★ 5/10
$0.9100 $0.4047▲ +55.53%▲ +56.71%$0.3659 (+59.79%)
May 28, 2026
18w ago
424B5
BEARISH ★ 6/10
$0.9100 $0.4047▲ +55.53%▲ +56.71%$0.3659 (+59.79%)
Apr 3, 2026
26w ago
EFFECT
BEARISH ★ 6/10
$1.14 $0.3970▲ +65.18%▲ +78.64%$0.3659 (+67.90%)
Showing 5 of 5

US Market Status

Market Open — Closes in 3h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access